cache/7862852e5ad4a7c6d00f912df8edc2cc9f8cbda1912880d2bd141dba59c0d05e

COM:ARROWHEADPHARMA

Arrowhead Pharmaceuticals

  • Privately Held

Arrowhead Pharmaceuticals focuses on developing therapies using RNA interference technology to target genes associated with diseases, particularly those with significant unmet medical needs. self-described as aiming to have numerous products in clinical trials or on the market by 2025.

peer of

competitor of